I think your comments regarding lack of resource at small companies are valid, however I do believe there is another large reason why clinical trials are often outsourced. Experience is another very important reason clinical trials are outsourced. Clinical trials are extremely complex and require staff with knowledge on how to comply with regulation requirements, recruit patients and manage data. Because many organizations that outsource these types of studies have developed systems in which they operate, outsourcing can result in less problems associated with the study's execution as well as efficiency and speed in completing the trial.
Regarding conflict of interest, I completely understand your point. A company conducting its own clinical trials may introduce a potential bias toward achieving a positive outcome for their product. By utilizing a third-party organization to conduct the clinical trial, it may provide a level of objectivity as well as create greater trustworthiness in the results. Although I don't see anything inherently unethical about a company conducting its own clinical trials, utilizing an independent third-party will certainly increase the reliability of the results.
Do you feel that the primary rationale behind the outsourcing of clinical trials is to expedite the process or to establish greater confidence and reliability in the results?

I agree with your point, especially about how the outsourcing is not just about smaller companies lacking resources, but also about access to expertise and efficiency. Even if a company has the ability to run trials in house, I think there are still a lot of reasons they would choose not to. Clinical trials are extremely complex and require very specific roles such as investigators, coordinators, regulatory teams, and access to patients, so outsourcing to a CRO that already has that infrastructure can save a lot of time and reduce risk. Additionally. I also think conflict of interest is definitely a factor, but I wouldn’t say it automatically makes it unethical for a company to run their own trials. As mentioned, everything still has to go through strict approval processes like the Food and Drug Administration and IRBs, so there are systems in place to reduce bias. Despite this, even if it is not unethical, outsourcing can still increase credibility because having an independent party collect and analyze the data makes the results look more objective. Another reason I think companies outsource is scalability and speed. CROs already have established patient networks, multiple sites, and experience running trials across different regions, which can make enrollment and data collection much faster compared to building everything from scratch. So overall, I would say outsourcing is not just about lack of resources, but also about efficiency, expertise, risk reduction, and credibility all working together.